Kim Won Seog, Honma Keiichiro, Karnan Sivasundaram, Tagawa Hiroyuki, Kim Yoon Duck, Oh Young Lyun, Seto Masao, Ko Young Hyeh
Division of Hemato-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Genes Chromosomes Cancer. 2007 Aug;46(8):776-83. doi: 10.1002/gcc.20463.
The genetic changes in marginal zone B cell lymphomas (MZBCL) vary according to the anatomical region. This study aimed to investigate genomic aberrations in ocular MZBCL and to compare them with those of tumors from other anatomical sites. The study population comprised 24 cases of primary ocular MZBCL, 11 pulmonary MZBCL, and seven nodal MZBCL. For array CGH, fresh tumor tissues were analyzed with a genome-wide scanning array containing 2,304 BAC/PAC clones which cover the whole human genome at a resolution of 1.3 Mb. FISH analysis for MALT1 gene alteration was performed for ocular and nodal MZBCL and RT-PCR for the detection of API2-MALT1 transcripts was performed for pulmonary MZBCL. The recurrent genomic alterations in ocular MZBCL were losses of chromosome bands 6q23.3 (9/24, 38%), 7q36.3 (2/24, 8%), and 13q34 (2/24, 8%), and gains of chromosomes 3 (9/24, 38%), and 15 (4/24, 16%), and chromosome arms 18q (4/24, 16%), and 6p (2/24, 8%). The t(11;18)(q21;q21) was not detected. The genomic alterations of pulmonary MZBCL included recurrent loss of 18q21 (2/11, 19%). A t(11;18)(q21;q21) fusion transcript was detected in five out of eight cases (63%). Nodal MZBCL showed neither recurrent genome alterations nor any change in MALT1 gene copy number. In conclusion, the array CGH profile of ocular MZBCL is distinct from those of pulmonary and nodal MZBCL. Deletion of chromosome band 6q23.3 in ocular MZBCL is a novel finding and may constitute a crucial genetic alteration in the pathogenesis of ocular MZBCL.
边缘区B细胞淋巴瘤(MZBCL)的基因变化因解剖部位而异。本研究旨在调查眼内MZBCL的基因组畸变,并将其与其他解剖部位肿瘤的畸变进行比较。研究人群包括24例原发性眼内MZBCL、11例肺MZBCL和7例淋巴结MZBCL。对于比较基因组杂交(array CGH),使用包含2304个BAC/PAC克隆的全基因组扫描阵列分析新鲜肿瘤组织,这些克隆以1.3 Mb的分辨率覆盖整个人类基因组。对眼内和淋巴结MZBCL进行MALT1基因改变的荧光原位杂交(FISH)分析,对肺MZBCL进行逆转录聚合酶链反应(RT-PCR)以检测API2-MALT1转录本。眼内MZBCL中反复出现的基因组改变为6q23.3染色体带缺失(9/24,38%)、7q36.3(2/24,8%)和13q34(2/24,8%),以及染色体3(9/24,38%)、15(4/24,16%)、染色体臂18q(4/24,16%)和6p(2/24,8%)的增加。未检测到t(11;18)(q21;q21)。肺MZBCL的基因组改变包括18q21的反复缺失(2/11,19%)。在8例中的5例(63%)中检测到t(11;18)(q21;q21)融合转录本。淋巴结MZBCL既未显示反复出现的基因组改变,MALT1基因拷贝数也未发生任何变化。总之,眼内MZBCL的array CGH图谱与肺和淋巴结MZBCL的不同。眼内MZBCL中6q23.3染色体带的缺失是一个新发现,可能是眼内MZBCL发病机制中的关键基因改变。